Andersons pediatric cardiology 2326
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (75.3 KB, 3 trang )
echocardiographyin,1014–1015,1014f–1015f
toevaluatecardiacinvolvement,1013–1014
supportingevidenceofrecentgroupAstreptococcalinfectionand,1012–1013
managementof,1015–1018
ofclinicalmanifestations,1016–1018
eradicationofgroupAstreptococcalinfectionand,1016,1016t
morphologyofacutecardiacandextra-cardiaclesionsin,1002–1004,1003f–1005f
preventionof,1018–1021
primary,1018–1019,1018b
primordial,1018
secondary,1020–1021,1020t–1021t
vaccinedevelopmentfor,1002
Streptococcusand,1000–1001,1000f
Acutevasoreactivitytesting,incatheterization,1388
Acute-phasereactants,inrheumaticfever,1013
Adams-Oliversyndrome,1417,1417t
Addisondisease,cardiacinvolvementin,1096–1097
Adenosinemonophosphate-activatedproteinkinasemutations,hypertrophic
cardiomyopathyand,1148
Adenosinetriphosphate-bindingcassettesuperfamily,1435
ADHF,Acutedecompensatedheartfailure
Adjustmentandadaptation,effectsofchild'scardiacdiseaseon,1459–1460
Adolescents,psychologicalstressofcardiacdiseasein,1456,1457t–1458t
Adrenalglandsuppression,inprematurity,201
Adrenaline,forcontrolofcirculation,1357
α-Adrenergicblockade,incardiopulmonarybypass,232
Adrenergicreceptorblockers(ARBs),forchronicheartfailure,1200
Adrenocorticalhypertension,1136
Adrenomedullin,1358
α-Adrenoreceptorblockers,forhypertension,1140,1140t
β-Adrenoreceptorblockers
fordilatedcardiomyopathy,1158
forhypertension,1140,1140t
Adultcongenitalheartdisease(ACHD),inchronicmechanicalcirculatory
support,1214
Adultshort-termleftVADs,1206
Advancedheartfailuretherapy,forcancertherapy-relatedcardiotoxicity,1172
Advancedsecond-degreeAVblock,338,338f
Adventitia,1356
Aerobiccapacity
exercisetestingand,391–392,392t
followingcardiactransplantation,1235–1236
AET,Atrialectopictachycardia
Afterload,increased,acutemyocardialdysfunctionwith,1179
β-agonists,foratrialtachyarrhythmias,139t
Agreement,measuresof,414
Airway,vascularcompressionof,withoutvascularringorsling,900,900f
AKI,Acutekidneydisease
Alagillesyndrome,1416,1416t
cardiacinvolvementin,1112
Aldosteroneantagonists,for“well”Fontan,1338–1339
Allocatingorgans,incardiactransplantation,1475
Allograft,vasculopathyofcardiac,1232–1233,1232f
riskfactorsanddiagnosisof,1225t,1232,1233f–1234f
treatmentof,1233
Alpha-adrenoreceptorblockers,forhypertension,1140,1140t
Alternativesplicing,ofprimarytranscript,67–68
Alveolarcapillarydysplasia,pulmonaryhypertensionand,1386
Ambulatoryrhythmmonitoring,forcancertherapy-relatedcardiotoxicity,1171
Ambulatorysettingand“medicalhome,”dischargeplanning,communications
with,teamprovidingcarein,1487–1494
case1,1487–1488
case2,1490–1492
case3,1492–1493
Amiodarone,foratrialtachyarrhythmias,139t,140
Amlodipineforhypertension,1140t
Amoxicillin
forinfectiveendocarditis,1053t
forrheumaticfeverprevention,1016t
Amoxycillin,forbloodculture-negativeendocarditis,1054t
Ampicillin,forbloodculture-negativeendocarditis,1054t
Amylo-1,6-glucosidasedeficiency,cardiacinvolvementin,1088–1089
Anakinra,forKawasakisyndrome,990
Anatomy,17–32
Ancillarytests,inhemodynamicallysignificantarterialduct,197
Andersendisease,cardiacinvolvementin,1089
Anderson-Fabrydisease,hypertrophiccardiomyopathyand,1149
Anemia,inprematurity,211
Anesthesia
incardiacsurgery,1399
incardiopulmonarybypass,229
forcomplexcongenitalcardiacdisease,1400
indiagnosticcatheterization,239
ininvasiveelectrophysiologicstudy,358–359
Anestheticconsiderations,forcardiacandnoncardiacsurgery,inchildwith
congenitalcardiacdisease,1547–1552
fordiagnosticandinterventionalcatheterization,1551
exposureonbraindevelopment,effectsof,1552
managementof,1548–1549
